Novel Wound Powder RGN107 to Reduce Wound Odor, Pain and Exudate at End-of-Life
新型伤口粉 RGN107 可减少临终时的伤口气味、疼痛和渗出物
基本信息
- 批准号:8640207
- 负责人:
- 金额:$ 18.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdmission activityAdverse effectsAffectAnecdotesBedsBurn injuryCaregiversCaringDataData CollectionDecubitus ulcerDistressDocumentationDrainage procedureEnrollmentExudateFaceFamilyFamily CaregiverFeasibility StudiesFrequenciesGoalsHealedHome environmentHospice CareHuman ResourcesIndividualInpatientsInterventionInterviewLearningLeg UlcerLicensingLife ExpectancyMeasurementMeasuresMethodsModelingMonitorMovementOdorsOutcomePainPain managementPainlessPalliative CarePatientsPerformancePerfusionPhysiologicalPopulationPowder dose formPrevalenceProceduresProcessProtocols documentationProviderQuality of lifeRecordsRegistered nurseResearchServicesSignal TransductionSourceSterile coveringsSurveysSymptomsTimeTissuesTrainingUlcerVenousVisitabsorptionbaseclinical efficacyclinical practicecomparativecostdesigneligible participantend of lifehealinghospice environmentimmune functionimprovedlensnovelorganizational structurepressurepreventprimary outcomepublic health relevancesatisfactionsealsecondary outcomeskin irritationsymptom managementtheoriestreatment as usualusabilitywound
项目摘要
DESCRIPTION: Palliative care can provide comfort and support for individuals at the end of life who have a wound. Such people frequently face distressing symptoms that profoundly affect quality of life. Wound care research on feasible comfort measures is minimal to address physical symptoms such as pain, odor, and wound drainage (exudate) that often accompany wounds that develop at the end of life. We propose to study a wound comfort intervention comprised of a low-cost wound powder, RGN107 that can be sprinkled on wounds using a squirt bottle. After several applications, the powder forms a "crust" seal border over the wound, protecting it from dressings that can stick to the fragile wound bed and preventing manipulation from wiping, both of which can cause pain. The goal is to augment usual wound care, adding to the comfort and quality of life of dying individuals as well as their caregivers. No previous studies have determined the feasibility of using a specially developed wound powder to examine adherence to a wound comfort protocol for individuals receiving hospice care. Our pilot data indicate that RGN107 is nontoxic, and efficacious, providing substantial relief from pain and exudate from venous leg ulcers. We propose to extend these findings to a highly challenging population of hospice enrollees with wounds such as pressure ulcers. Approximately 50% of the individuals who develop wounds have tried various methods to manage symptoms, but continue to suffer from uncontrolled wound pain, odor, and exudate. The purpose of our study is to examine the feasibility of an enhanced wound care approach and examine monitoring of adherence, measures of signals of efficacy in the control of symptoms, and impact on quality of life after use of RGN107. This R21 will employ a comparative group design to determine feasibility in two models of a hospice organization, home based care and inpatient hospice that will target 50 individuals with life expectancies more than 1 month, but less than 6 months. We will tailor the training for each model recognizing the variability of caregivers. In the inpatient
setting, training will be delivered over the three shifts and over several days. In the home, the registered nurses that plan wound care, along with associated agency and family caregivers will be instructed in the home setting over several training sessions. A DVD of wound procedures will be used to reinforce learning. Our team will monitor adherence by fidelity processes such as making regular visits to assess caregiver performance, evaluating the wound itself, and reviewing documentation. Data collection sources include project records, patient/provider logs, surveys and interviews conducted at three time points, baseline, and then weeks 2 and 4. We hypothesize our intervention will enhance comfort care and quality of life at the end of life for both the patient and the caregiver.
描述:姑息治疗可以为临终时有伤口的人提供安慰和支持。这些人经常面临严重影响生活质量的痛苦症状。关于可行的舒适措施的伤口护理研究很少能解决临终时伤口经常出现的疼痛、气味和伤口引流(渗出物)等身体症状。我们建议研究一种伤口舒适干预措施,该干预措施由低成本伤口粉末 RGN107 组成,可以使用喷瓶将其喷洒在伤口上。多次使用后,粉末会在伤口上形成一层“硬壳”密封边界,保护伤口免受敷料粘在脆弱的伤口床上的影响,并防止擦拭,这两种情况都会引起疼痛。其目标是加强日常伤口护理,提高临终者及其护理人员的舒适度和生活质量。之前没有研究确定使用专门开发的伤口粉末来检查接受临终关怀的个人对伤口舒适方案的遵守情况的可行性。我们的试验数据表明,RGN107 无毒且有效,可显着缓解腿部静脉溃疡的疼痛和渗出物。我们建议将这些发现扩展到具有压疮等伤口的临终关怀参与者中极具挑战性的人群。大约 50% 的伤口患者尝试过各种方法来控制症状,但仍然遭受不受控制的伤口疼痛、气味和渗出液的困扰。我们研究的目的是检查强化伤口护理方法的可行性,并检查依从性监测、控制症状的功效信号测量以及使用 RGN107 后对生活质量的影响。 R21 将采用比较组设计来确定临终关怀组织、家庭护理和住院临终关怀两种模式的可行性,该模式将针对 50 名预期寿命超过 1 个月但不到 6 个月的个体。我们将为每个模型量身定制培训,以认识到护理人员的可变性。在住院部
培训将分三班制、持续几天进行。在家里,计划伤口护理的注册护士以及相关机构和家庭护理人员将在家里接受多次培训课程的指导。将使用伤口手术 DVD 来强化学习。我们的团队将通过保真流程来监控遵守情况,例如定期拜访以评估护理人员的表现、评估伤口本身以及审查文件。数据收集来源包括项目记录、患者/提供者日志、在三个时间点、基线以及第 2 周和第 4 周进行的调查和访谈。我们假设我们的干预措施将增强患者和护理人员临终时的舒适护理和生活质量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Teresa J Kelechi其他文献
Teresa J Kelechi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Teresa J Kelechi', 18)}}的其他基金
A Social Genomics Model to Explore Loneliness and Systemic Inflammation in an Older Adult Population with Chronic Venous Leg Ulcers
探索患有慢性静脉腿部溃疡的老年人群的孤独感和全身炎症的社会基因组学模型
- 批准号:
10259779 - 财政年份:2020
- 资助金额:
$ 18.66万 - 项目类别:
A Social Genomics Model to Explore Loneliness and Systemic Inflammation in an Older Adult Population with Chronic Venous Leg Ulcers
探索患有慢性静脉腿部溃疡的老年人群的孤独感和全身炎症的社会基因组学模型
- 批准号:
10056870 - 财政年份:2020
- 资助金额:
$ 18.66万 - 项目类别:
Technology Enhanced Self-Management Interventions for Fatigue and Pain: The Symptoms Self Management Center
技术增强疲劳和疼痛的自我管理干预措施:症状自我管理中心
- 批准号:
9321923 - 财政年份:2016
- 资助金额:
$ 18.66万 - 项目类别:
Technology Enhanced Self-Management Interventions for Fatigue and Pain: The Symptoms Self Management Center
技术增强疲劳和疼痛的自我管理干预措施:症状自我管理中心
- 批准号:
10115249 - 财政年份:2016
- 资助金额:
$ 18.66万 - 项目类别:
Technology Enhanced Self-Management Interventions for Fatigue and Pain: The Symptoms Self Management Center
技术增强疲劳和疼痛的自我管理干预措施:症状自我管理中心
- 批准号:
9187327 - 财政年份:2016
- 资助金额:
$ 18.66万 - 项目类别:
Technology Enhanced Self-Management Interventions for Fatigue and Pain: The Symptoms Self Management Center
技术增强疲劳和疼痛的自我管理干预措施:症状自我管理中心
- 批准号:
9926923 - 财政年份:2016
- 资助金额:
$ 18.66万 - 项目类别:
Physical Activity Interventions for Leg Ulcer Patients
腿部溃疡患者的身体活动干预措施
- 批准号:
9070782 - 财政年份:2015
- 资助金额:
$ 18.66万 - 项目类别:
Monitoring and Managing Newly Healed Chronic Leg and Foot Ulcer Skin Temperature: A Cooling Intervention (MUSTCOOL) to Prevent Ulcer Recurrence
监测和管理新愈合的慢性腿部和足部溃疡皮肤温度:预防溃疡复发的降温干预措施 (MUSTCOOL)
- 批准号:
9088519 - 财政年份:2015
- 资助金额:
$ 18.66万 - 项目类别:
Monitoring and Managing Newly Healed Chronic Leg and Foot Ulcer Skin Temperature: A Cooling Intervention (MUSTCOOL) to Prevent Ulcer Recurrence
监测和管理新愈合的慢性腿部和足部溃疡皮肤温度:预防溃疡复发的降温干预措施 (MUSTCOOL)
- 批准号:
8896939 - 财政年份:2015
- 资助金额:
$ 18.66万 - 项目类别:
Monitoring and Managing Newly Healed Chronic Leg and Foot Ulcer Skin Temperature: A Cooling Intervention (MUSTCOOL) to Prevent Ulcer Recurrence
监测和管理新愈合的慢性腿部和足部溃疡皮肤温度:预防溃疡复发的降温干预措施 (MUSTCOOL)
- 批准号:
9244684 - 财政年份:2015
- 资助金额:
$ 18.66万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 18.66万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 18.66万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 18.66万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 18.66万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 18.66万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 18.66万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 18.66万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 18.66万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 18.66万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 18.66万 - 项目类别:
Fellowship Programs